(Q34951157)

5 August 2017

title

Intratumoral anti-HuD immunotoxin therapy for small cell lung cancer and neuroblastoma (English)

1 reference

5 August 2017

1 reference

Debra Ehrlich

1

1 reference

5 August 2017

Bo Wang

2

1 reference

5 August 2017

Wei Lu

3

1 reference

5 August 2017

Peter Dowling

4

1 reference

5 August 2017

Ruirong Yuan

5

1 reference

5 August 2017

publication date

19 December 2014

1 reference

Journal of Hematology & Oncology

5 August 2017

published in

1 reference

5 August 2017

volume

7

1 reference

5 August 2017

page(s)

91

1 reference

Creative Commons Attribution 4.0 International

5 August 2017

copyright license

start time

1 December 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4293823

Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4293823

Selective tropism of Seneca Valley virus for variant subtype small cell lung cancer.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4293823

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4293823

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4293823

Ipilimumab in combination with paclitaxel and carboplatin as first-line treatment in stage IIIB/IV non-small-cell lung cancer: results from a randomized, double-blind, multicenter phase II study.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4293823

Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4293823

Capsaicin displays anti-proliferative activity against human small cell lung cancer in cell culture and nude mice models via the E2F pathway

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4293823

Receptor-directed therapy of T-cell leukemias and lymphomas

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4293823

CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4293823

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4293823

Immunotoxins and vascular leak syndrome

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4293823

DNA vaccination with HuD inhibits growth of a neuroblastoma in mice.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4293823

Cell surface expression of paraneoplastic encephalomyelitis/sensory neuronopathy-associated Hu antigens in small-cell lung cancers and neuroblastomas

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4293823

Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4293823

The expression of the Hu (paraneoplastic encephalomyelitis/sensory neuronopathy) antigen in human normal and tumor tissues

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4293823

Immunotoxin studies in a model of human T-cell acute lymphoblastic leukemia developed in severe combined immune-deficient mice

8 July 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13045-014-0091-3

Intratumoral CD8+ T lymphocytes as a prognostic factor of survival in endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13045-014-0091-3

miR-9 controls the timing of neurogenesis through the direct inhibition of antagonistic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13045-014-0091-3

Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13045-014-0091-3

Ipilimumab in combination with paclitaxel and carboplatin as first-line therapy in extensive-disease-small-cell lung cancer: results from a randomized, double-blind, multicenter phase 2 trial

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4293823

Internalization of monoclonal antibodies selected for immunotoxin activity against small-cell lung cancer

26 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25523825

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The behavioral and neuroanatomical effects of IB4-saporin treatment in rat models of nociceptive and neuropathic pain

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25523825

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Immunotoxins for targeted cancer therapy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25523825

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/S13045-014-0091-3

1 reference

Dimensions Publication ID

5 August 2017

0 references

1 reference

5 August 2017

1 reference